ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS Russian patent published in 2013 - IPC C07K16/18 A61K39/395 A61K38/02 A61P19/10 

Abstract RU 2475499 C2

FIELD: chemistry.

SUBSTANCE: invention discloses an antibody or a functional fragment thereof, which specifically identifies a polypeptide coded by a gene in the human body, and inhibits formation of osteoclasts and, optionally, osteoclastic bone resorption. The antibody or functional fragment thereof can be obtained particularly by hybridoma technology using hybridoma #32A1(FERM BP-10999) and #41B1 (FERM BP-11000) disclosed in the invention. Described is a pharmaceutical composition based on the antibody or functional fragment thereof for treating and/or preventing bone pathobolism in a patient, as well as methods of treating and preventing anomalous metabolism of bone tissue using antibodies or functional fragments thereof.

EFFECT: use of the invention enables specific identification gene-expressed human Siglec-15 using the disclosed antibody and inhibit formation of osteoclasts.

39 cl, 80 dwg, 9 tbl, 38 ex

Similar patents RU2475499C2

Title Year Author Number
Siglec-15 ANTIBODY 2010
  • Khiruma Josikharu
  • Tsuda Ejsuke
  • Takizava Takesi
  • Nakajama Makiko
RU2539790C2
PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) 1998
  • Jamaguti Kiodzi
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Sima Nobujuki
  • Kinosaki Masakhiko
  • Tsuda Eisuke
  • Goto Masaaki
  • Jano Kazuki
  • Tomojasu Akikhiro
  • Kobajasi Fumie
  • Vasida Naokhiro
  • Takakhasi Ken
  • Morinaga Tomonori
  • Khigasio Kandzi
RU2238949C2
T CELL ADHESION MOLECULE AND ANTIBODY AGAINST SAID MOLECULE 2006
  • Ogasavara Khideaki
  • Mizuno Kejko
  • Arita Josikhisa
  • Nisimura Mijuki
  • Imai Tosio
RU2396275C2
NOVEL PROTEINS AND METHODS OF THEIR PREPARING 1996
  • Goto Masaaki
  • Tsuda Ehjsuke
  • Motizuki Siniti
  • Jano Kazuki
  • Kobajasi Fumie
  • Sima Nobujuki
  • Jasuda Khisataka
  • Nakagava Nobuaki
  • Morinaga Tomonori
  • Ueda Masatsugu
  • Khigasio Kandzi
RU2194714C2
ANTIGEN MOLECULAR MASSIFS 2003
  • Bakhmann Martin F.
  • Tisso Allan
  • Pampens Paul'
  • Sielens Indulis
  • Renkhofa Regina
RU2324704C2
NON-MOUSE ANTI-M-CSF-ANTIBODY (VERSIONS), PREPARATION AND USE THEREOF 2005
  • Lju Chehn
  • Tsimmerman Debora Li
  • Khehrroui Gregori Martin
  • Kots Kirston
  • Kavanaf Uill'Jam Majkl
  • Long Li
  • Kal'Deron-Kasia Marija
  • Khorvits Arnol'D Kh.
RU2401277C2
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION 2013
  • Okano Fumiesi
  • Saito Takanori
  • Ido Takaesi
  • Minamida Esitaka
RU2631804C2
ANTIGEN MATRIX FOR TREATMENT OF BONE DISEASE 2002
  • Bakhmann Martin
  • Maurer Patrik
  • Shpon Gjunter
RU2322258C2
COMPOSITION AND METHOD FOR IMMUNISATION, METHOD OF PRODUCING UNNATURAL, ORDERED AND REPEATING MASSIVE OF ANTIGENS 2002
  • Renner Vol'Fgang A.
  • Bakhmann Martin
  • Tisso Alen
  • Maurer Patrik
  • Lekhner Frantsiska
  • Zebbel' Peter
  • Piossek Kristine
RU2438701C2
COMPOSITION AND IMMUNIZATION METHOD, METHODS FOR PRODUCING NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE AND COAT PROTEIN 2002
  • Renner Vol'Fgang A.
  • Bakhmann Martin
  • Tisso Alen
  • Maurer Patrik
  • Lekhner Frantsiska
  • Zebbel' Peter
  • Piossek Kristine
RU2295973C2

RU 2 475 499 C2

Authors

Khiruma Josikharu

Tsuda Ejsuke

Dates

2013-02-20Published

2008-10-08Filed